Grant: Research Tools and Instruments - Category 1 (<$150,000)
University of Toronto
$75,661.00
Instrument for characterization of plymers and solute release kinetics
EF 2008-09
Résumé
Biocompatible polymers have been widely used to make various advanced medications such as once daily blood-pressure-controlling pills that provide more effective treatment with lower side effects than conventional medications. The properties of polymers such as molecular weight and dissolving rate determine when and how fast the medicine will take effect thus affecting the therapeutic benefit of such medications. Unlike small molecules, polymers prepared in one reaction can have different molecular weights, and some polymers degrade during application thus controlling the release rate of therapeutic agents from the medications.
Dr. Wu laboratory, funded by NSERC, is developing novel advanced medications using biocompatible and biodegradable polymers; is investigating how polymer properties influence its interaction with therapeutic agents, polymer hydration, swelling and dissolution, and thereby release kinetics of the encased therapeutic agents. These properties determine the performance of the new medications in human body. Dr. Sun laboratory is collaborating with Dr. Wu to develop new techniques to integrate glucose-responsive nano-hydrogel composite membranes with MEMS (microelectromechanical systems) structures to form new types of device that release insulin based the blood sugar concentrations. In this NSERC/CIHR co-funded CHRP project insulin release behavior and stability will be studied. These studies need an instrument, called gel permeation chromatography (GPC)/high performance liquid chromatography (HPLC) instrument, to analyze the molecular weight and distribution of polymers, and to assay various compounds and therapeutic agents, including insulin, released from the medications into a medium. The requested instrument will separate the polymers based on their molecular weights and the compounds based on their affinity to the packing material connected with the instrument. A grant for purchasing the GPC/HPLC instrument will help design new medications.
Programme
Research Tools and Instruments - Category 1 (<$150,000)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
374799-2009
Name nom
Wu, XiaoYu(Shirley)
Department département
Pharmacy, Leslie Dan Faculty of
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2009
Award amount
75661
Program id
EQPEQ
Program nane en
Research Tools and Instruments - Category 1 (<$150,000)
Program name fr
Outils et instruments de recherche - catégorie 1 (<150 000$)
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
4
Committee name en
Chem. & Metallurgical Eng.
Committee name fr
Génies chimique et métal.
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
1
Nb partie
1
Application title
Instrument for characterization of plymers and solute release kinetics
Keyword
NA
Application summary
Biocompatible polymers have been widely used to make various advanced medications such as once daily blood-pressure-controlling pills that provide more effective treatment with lower side effects than conventional medications. The properties of polymers such as molecular weight and dissolving rate determine when and how fast the medicine will take effect thus affecting the therapeutic benefit of such medications. Unlike small molecules, polymers prepared in one reaction can have different molecular weights, and some polymers degrade during application thus controlling the release rate of therapeutic agents from the medications.
Dr. Wu laboratory, funded by NSERC, is developing novel advanced medications using biocompatible and biodegradable polymers; is investigating how polymer properties influence its interaction with therapeutic agents, polymer hydration, swelling and dissolution, and thereby release kinetics of the encased therapeutic agents. These properties determine the performance of the new medications in human body. Dr. Sun laboratory is collaborating with Dr. Wu to develop new techniques to integrate glucose-responsive nano-hydrogel composite membranes with MEMS (microelectromechanical systems) structures to form new types of device that release insulin based the blood sugar concentrations. In this NSERC/CIHR co-funded CHRP project insulin release behavior and stability will be studied. These studies need an instrument, called gel permeation chromatography (GPC)/high performance liquid chromatography (HPLC) instrument, to analyze the molecular weight and distribution of polymers, and to assay various compounds and therapeutic agents, including insulin, released from the medications into a medium. The requested instrument will separate the polymers based on their molecular weights and the compounds based on their affinity to the packing material connected with the instrument. A grant for purchasing the GPC/HPLC instrument will help design new medications.